Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID
- PMID: 36196612
- PMCID: PMC9533168
- DOI: 10.3947/ic.2022.0141
Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID
Abstract
Long-lasting coronavirus disease 2019 (COVID-19) symptoms beyond 12 weeks, the so-called 'long COVID' have been increasingly reported worldwide. Long COVID can be manifested in various forms, and there is an increasing demand for proper assessment and management. However, it is challenging when trying to determine the best-practice standards of care based on the current evidence because there is no internationally agreed clinical definition or clear treatment pathway. Therefore, the present guidelines have been drafted to provide advice on diagnosis and management based on the latest updated available evidence and the consensus of expert opinion. So far, no standard test and drug treatment can be strongly recommended for patients with long COVID because of a lack of evidence. The present guidelines provide advice based on 12 key questions, including appropriate interventions for long COVID that can be used in clinical practice. Continuous careful observation and studies related to long COVID are needed for the long-term impact of COVID-19 and proper management for long COVID to be determined.
Keywords: Long COVID; Management; Persistent symptoms; Post-COVID condition; SARS-CoV-2.
Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Conflict of interest statement
No conflict of interest.
Figures
Similar articles
-
Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID.Infect Chemother. 2024 Mar;56(1):122-157. doi: 10.3947/ic.2024.0024. Epub 2024 Mar 13. Infect Chemother. 2024. PMID: 38527781 Free PMC article. Review.
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
-
Neurological manifestations of long-COVID syndrome: a narrative review.Ther Adv Chronic Dis. 2022 Feb 17;13:20406223221076890. doi: 10.1177/20406223221076890. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35198136 Free PMC article. Review.
Cited by
-
Clinical practice guidelines and expert consensus statements on rehabilitation for patients with COVID-19: a systematic review.BMJ Open. 2024 Sep 10;14(9):e086301. doi: 10.1136/bmjopen-2024-086301. BMJ Open. 2024. PMID: 39260851 Free PMC article.
-
The effects of G1899 Korean red ginseng extract powder on long COVID for acute COVID19 infection: A randomized, double-blind, placebo-controlled trial.J Ginseng Res. 2025 Jul;49(4):470-477. doi: 10.1016/j.jgr.2025.04.007. Epub 2025 Apr 24. J Ginseng Res. 2025. PMID: 40621076 Free PMC article.
-
Association between long COVID and nonsteroidal anti-inflammatory drug use by patients with acute-phase COVID-19: A nationwide Korea National Health Insurance Service cohort study.PLoS One. 2024 Nov 22;19(11):e0312530. doi: 10.1371/journal.pone.0312530. eCollection 2024. PLoS One. 2024. PMID: 39576781 Free PMC article.
-
Prevalence, Risk Factors, and Impact of Long COVID Among Adults in South Korea.Healthcare (Basel). 2024 Oct 17;12(20):2062. doi: 10.3390/healthcare12202062. Healthcare (Basel). 2024. PMID: 39451477 Free PMC article.
-
Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review.Clin Respir J. 2024 May;18(5):e13777. doi: 10.1111/crj.13777. Clin Respir J. 2024. PMID: 38775379 Free PMC article. Review.
References
-
- World Health Organization (WHO) WHO coronavirus (COVID-19) dashboard. [Accessed 15 June 2022]. Available at: https://covid19.who.int/
-
- National Institute for Health and Care Excellence (NICE) COVID-19 rapid guideline: managing the long-term effects of COVID-19. [Accessed 15 June 2022]. Available at: https://www.nice.org.uk/guidance/ng188. - PubMed
-
- National Institutes of Health (NIH) NIH launches new initiative to study “Long COVID”. [Accessed 13 June 2022]. Available at: https://covid19.nih.gov/covid-19-topics/long-covid.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous